24–25 Nov 2026
IARC
Europe/Paris timezone

From Adiposity to Organ Dysfunction: Physical Activity, Diet, and the Risk of Clinical Obesity in the UK Biobank

T1-2
24 Nov 2026, 09:50
10m
RC 150 - Auditorium (IARC)

RC 150 - Auditorium

IARC

25 avenue Tony Garnier, Lyon, France
Short oral Cancer Etiology, Epidemiology & Risk Factors Cancer Etiology, Epidemiology & Risk Factors

Speaker

Dr Alem Abraha (IARC)

Description

Background: Physical activity (PA) and diet are key modifiable lifestyle factors influencing obesity. Understanding the transition from preclinical to clinical obesity is important because clinical obesity is associated with substantially greater health risks. However, the role of lifestyle factors in this transition remains poorly understood. We assessed the independent and joint associations of PA and diet quality with the risk of progression from preclinical to clinical obesity.
Methods: We analyzed 159,959 UK Biobank participants with preclinical obesity. Individuals with baseline cancer, cardiovascular disease, organ dysfunction, or without excess body fat were excluded. PA and diet were assessed at baseline using self-reported questionnaires. PA was quantified as metabolic equivalent (MET)-hours/week, and diet quality was summarized using a score based on major food groups. Incident clinical obesity was defined as the first ICD-coded event attributable to excess body fat, according to the Lancet Diabetes & Endocrinology Commission framework. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for independent and joint associations. Preventive fractions for the population (PFPs) were calculated using adjusted HRs and exposure prevalence among cases.
Results: During a median follow-up of 14 years, 66,697 participants progressed to clinical obesity, corresponding to an incidence rate of 33.2 per 1,000 person-years. Higher PA (HR 0.92, 95% CI 0.90-0.94) and better diet quality (HR 0.94, 95% CI 0.93-0.96) were each associated with lower risk. Participants with both higher PA and better diet quality had the lowest risk (HR 0.87, 95% CI 0.84-0.90). The corresponding PFPs were 4.8%, 1.9%, and 6.0%, respectively.
Conclusions: Higher PA and better diet quality, particularly in combination, were associated with a reduced risk of progression from preclinical to clinical obesity, supporting integrated lifestyle interventions for obesity prevention.

Author

Dr Alem Abraha (IARC)

Co-authors

Dr Heinz Freisling (Nutrition and Metabolism Branch, International Agency for Research on Cancer) Dr Michael J. Stein (2 Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee)

Presentation materials

There are no materials yet.